Systemic Preexposure Prophylaxis for Human Immunodeficiency Virus Infection (Q37793090)

23 August 2017

title

Systemic preexposure prophylaxis for human immunodeficiency virus infection (English)

1 reference

23 August 2017

Systemic Preexposure Prophylaxis for Human Immunodeficiency Virus Infection (English)

1 reference

https://api.crossref.org/works/10.1592/PHCO.30.10.1021

21 July 2024

author name string

Frank Romanelli

1

1 reference

23 August 2017

Brian Murphy

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1592%2Fphco.30.10.1021

1 reference

https://api.crossref.org/works/10.1592/PHCO.30.10.1021

https://onlinelibrary.wiley.com/doi/full/10.1592/phco.30.10.1021

21 July 2024

1 reference

https://api.crossref.org/works/10.1592/PHCO.30.10.1021

21 July 2024

1 reference

23 August 2017

volume

30

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1021-1030

1 reference

The survival benefits of AIDS treatment in the United States

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

The immune response during acute HIV-1 infection: clues for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Oral pre-exposure prophylaxis for HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

The pharmacokinetics and viral activity of tenofovir in the male genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Phospholipase D in the human ocular surface and in pterygium

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Pre-exposure prophylaxis for HIV infection: what if it works?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Global epidemiology of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Knowledge and Use of HIV Pre-Exposure Prophylaxis Among Attendees of Minority Gay Pride Events, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Knowledge and Use of Preexposure and Postexposure Prophylaxis Among Attendees of Minority Gay Pride Events, 2005 Through 2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.10.1021

Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis

21 January 2018

8

1 reference

https://api.crossref.org/works/10.1592/PHCO.30.10.1021

Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1.

21 July 2024

19

1 reference

https://api.crossref.org/works/10.1592/PHCO.30.10.1021

Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates

21 July 2024

31

1 reference

https://api.crossref.org/works/10.1592/PHCO.30.10.1021

Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men

21 July 2024

38

1 reference

https://api.crossref.org/works/10.1592/PHCO.30.10.1021

21 July 2024

Identifiers

1 reference

23 August 2017

1 reference